These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1361547)

  • 1. The effects of labetalol and dilevalol on isolated cardiovascular preparations of the guinea-pig and rat.
    Doggrell SA
    J Pharm Pharmacol; 1992 Dec; 44(12):1001-6. PubMed ID: 1361547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
    Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (+/-)-, (+)- and (-)-celiprolol on the rat left atria and portal vein.
    Doggrell SA
    J Pharm Pharmacol; 1992 Mar; 44(3):239-43. PubMed ID: 1354732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.
    Matsunaga K; Nakamura K; Ueda M
    J Pharmacobiodyn; 1985 Sep; 8(9):785-7. PubMed ID: 2868089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
    Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
    Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bromoacetylalprenololmenthane (BAAM), an irreversible beta-adrenoceptor antagonist, on the rat isolated left atria and portal vein.
    Doggrell SA
    J Auton Pharmacol; 1990 Dec; 10(6):333-44. PubMed ID: 1982668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxant and beta 2-adrenoceptor blocking activities of labetalol, dilevalol, amosulalol and KF-4317 on the rat isolated aorta.
    Doggrell SA
    J Pharm Pharmacol; 1988 Nov; 40(11):812-5. PubMed ID: 2907566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
    Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
    Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dilevalol on human atrial muscle.
    Brown MJ; Sanders L
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():55-8. PubMed ID: 2370644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of dilevalol on adrenoceptors.
    Louis WJ; Drummer OH; Tung LH
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S5-11. PubMed ID: 2464095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.
    O'Donnell SR; Wanstall JC
    Br J Pharmacol; 1985 Jan; 84(1):227-35. PubMed ID: 2858232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dilevalol on adrenoceptors in isolated cat arteries.
    Nakajima M; Ueda M
    J Pharmacobiodyn; 1990 Nov; 13(11):696-704. PubMed ID: 1965509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+/-)-Govadine and (+/-)-THP, two tetrahydroprotoberberine alkaloids, as selective alpha 1-adrenoceptor antagonists in vascular smooth muscle cells.
    Ko FN; Chang YL; Chen CM; Teng CM
    J Pharm Pharmacol; 1996 Jun; 48(6):629-34. PubMed ID: 8832499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the adrenoceptor activity of AY-28,925.
    Rimele TJ; Heaslip RJ; Lee DK; Grimes D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):1-8. PubMed ID: 2876089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
    Haynes JM; Hill SJ
    Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of labetalol and SCH 19927, the R1R isomer of labetalol, on the rat isolated right ventricle and aorta.
    Doggrell SA; Hughes EW
    J Auton Pharmacol; 1985 Dec; 5(4):279-88. PubMed ID: 4093453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.
    Mian MA; Malta E; Raper C
    J Pharm Pharmacol; 1984 Oct; 36(10):698-9. PubMed ID: 6150092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.